Chelation Therapy In Switzerland -- Prevents Cancer
|
Chelation |
Chelation Therapy
(key-LAY-shun)
Cardiovascular Diseases
New Help For:
- heart disease
- high blood pressure
- failing memory or sight
A little-known therapy just a few years ago, chelation (key-LAY-shun) is now gaining attention as a viable alternative to coronary bypass surgery, angioplasty and circulation problems.
Chelation therapy is the intravenous administration of an artificial amino acid (EDTA) combined with other nutrients to remove toxic metals. These toxic metals increase the amount of destructive chemical substances which cause cellular breakdown and contribute to hardening of the arteries.
According to the book Forty Something Forever, written by Harold and Arline Brecher,the procedure helps your body decrease plaque in the arteries and increase blood flow to organs and extremities. The scientific research they reviewed shows:
-
"Inhibition of platelet aggregation (blood stickiness) in humans within three minutes of EDTA infusion;
-
12 to 20% improved pulmonary [lung] function ... following 30 chelation treatments in 90.5% of 38 patients with independently diagnosed chronic lung disorders;
-
Marked improvement in 91% (and good improvement in 8%) in 1,130 patients with peripheral vascular disease [hardening of the arteries] and intermittent claudication [pain in legs upon walking] over a 28-month treatment period;
-
Marked improvement in 76.9% (and good improvement in 17%) of 844 patients with ischemic heart disease over a 28-month treatment period;
-
Marked or good improvement in 89% of all 2,870 patients treated over a 28-month period, no matter what their presenting health problems; ...
-
35% reduction in serious (76.63%) carotid artery blockage and 620% increase in blood flow in 16 men and women after ten months of EDTA infusions; ...
-
Documented evidence of the long-term success of EDTA chelation as an alternative to amputation in four patients originally scheduled for surgery."
After providing Chelation Therapy for a number of years, we have come across outstanding stories and statistics regarding this marvelous treatment. For example we would like to share some findings dealing with EDTA Chelation from a recent article: According to Alternative Medicine Review, Volume 3, 1 , 1998,"...although it has not been subjected to vast numbers of clinical trials, two meta-analysises suggest EDTA chelation therapy benefits cardiovascular symptoms in more than four out of five patients. In 1993, Chappell and Stahl published an analysis of data on 22,765 patients, compiled from 19 published clinical studies. They found a correlation coefficient of 87 percent between EDTA therapy and improved cardiovascular symptomatology based on objective testing. Subsequently, they obtained unpublished file drawer data on 1,241 objectively-sorted patients from 32 clinicians. From this approach they obtained a correlation co-efficient of 88 percent, further building the case for cardiovascular benefit from EDTA.
Danish physicians Hancke and Flytlie reported retrospectively on 470 patients with atherosclerosis. Of 65 patients awaiting bypass surgery and subjected to chelation, the vast majority showed clinical improvement; when chelation was completed only seven still required bypass. Of 27 patients previously scheduled for leg amputation, only three required surgery following courses of chelation therapy. These enticing results from EDTA chelation invite a well controlled comparison of chelation and revascularization, with the hope of being able to replace surgical revascularization techniques or to use chelation as an adjunct to these interventions.
We'd like to give you some interesting history about Chelation Therapy and cancer. Beginning in 1958, a lengthy study was conducted in Switzerland on 231 adults who lived near a well-traveled highway and had a higher rate of cancer mortality than other people in the same city that lived in traffic-free areas. The study group also suffered from a higher incidence of nervous disorders, headaches, fatigue, gastrointestinal disorders, depression and substance abuse. The researchers suggested that their symptoms might be due to a higher level of exposure to lead from automobile exhausts. Then, in 1961, 59 patients from this group received ten or more EDTA chelation treatments served as control subjects. An eighteen-year follow-up study of the group conducted by Walter Blumer, M.D. of Nestal, Switzerland revealed that only one of the 59 treated patients died of cancer (1.7 percent) as compared to thirty deaths (17.6 percent) from cancer among the non-treated subjects. This is a 90 percent reduction of mortality from cancer. Dr. Blumer found that death from atherosclerosis was also reduced among the treated patients. His findings were based upon Swiss death certificates and statistical evidence showing that EDTA chelation therapy was the only significant difference between the control group and the treated patients. This information was resourced from Burton Goldberg's book, Alternative Therapies.
Call
512-451-8149
for
Free Consultation
or more information.